HMGN2 · Western blot design guide

HMGN2 Western Blot Planning Guide

Plan a HMGN2 Western blot around the catalog-observed 9.4 kDa band, image-backed A04839-2 evidence, HPA controls, and verified protocol records.

Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use

Western blot protocol sheet for HMGN2 (HMGN2): expected band 9.4 kDa, antibody A04839-2, and PMC-cited SDS-PAGE protocol steps

Band Protocols Controls Antibodies

HMGN2 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running

	Expected band	9.4 kDa
	Observed band	Not reported — verify product WB image
	Gel	15%
	Positive control ⓘ	Lung
	Negative control ⓘ	Target knockdown/knockout

Important caveats

Reasons your observed band may differ from the expected size.

ⓘ	Calculated mass	9.4 kDa
ⓘ	Localization	Nucleus / Cytoplasm
ⓘ	Processing / PTM	Record-dependent
ⓘ	Reactivity	Human

Sample controls for HMGN2 Western blot

🧪Use Lung as the first positive-control candidate; no defensible HPA Not detected tissue was available, so use a target knockdown/knockout negative control.

Positive control: Lung (High)

Negative control: Target knockdown/knockout

HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for HMGN2

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue	Cell type	Level	Evidence	Source
Lung	Reported tissue cells	High	Protein (HPA)	HPA →
Gallbladder	Reported tissue cells	High	Protein (HPA)	HPA →
Caudate	Reported tissue cells	High	Protein (HPA)	HPA →
Bone marrow	Reported tissue cells	High	Protein (HPA)	HPA →

Undetected expression · recommended negative controls

Tissue	Cell type	Level	Evidence	Source

No HPA Not detected tissue is available; use a target knockdown/knockout negative control.

Section 1

What Is the Expected HMGN2 Western Blot Band Size?

Use the product-observed 9.4 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
9.4 kDa	Matches the authoritative product WB observation.
9.4 kDa calculated	Use as UniProt context, not as a replacement observed band.
Unexpected additional signal	Do not assign identity without orthogonal positive/negative controls.

💡Expected HMGN2 appearancePlan around 9.4 kDa and keep the calculated mass as supporting context.

How each factor affects band size
Catalog-observed band	9.4 kDa; use this as the primary experimental expectation.
Calculated mass	9.4 kDa from UniProt P05204; retain as context.
Gel selection	15%; shared with the recommended protocol and poster.
Specificity check	Compare the lead HPA positive and negative controls with A04839-2.

Why is my band missing or off?
Situation	Likely cause	Next action
9.4 kDa	Matches the authoritative product WB observation.	Confirm with orthogonal controls and the linked product record.
Additional band	May reflect processing, modification, or non-specific signal.	Run a dilution series and compare positive/negative controls.
Weak signal	Target abundance or transfer may be limiting.	Verify transfer, increase positive-control abundance, and bracket exposure.

Sources: UniProt P05204 Human Protein Atlas product datasheet (A04839-2)

Experiment evidence

Western blot images showing HMGN2 band

A04839-2 · HMGN2 — observed 9.4 kDa WB validation

A04839-2 · HMGN2Observed 9.4 kDa · product-specific WB image

← swipe / scroll for more images →

Real WB data behind the band-size expectations in this section.

Section 2

Real Curated HMGN2 Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysate	Bone marrow
Gel %	15%
Load	20-30 µg total protein per lane
Transfer	Semi-dry, short transfer
Membrane	0.2 µm PVDF
Blocking	5% non-fat milk or 5% BSA in TBST
Primary	A04839-2 at datasheet starting dilution
Primary incubation	Overnight at 4 °C with gentle agitation
Secondary	Species-matched HRP conjugate at validated dilution
Wash	3 × 5 min in TBST
Detection	Chemiluminescent substrate
Exposure	Bracket exposures to avoid saturation

Section 4

Advanced HMGN2 Western Blot Tips

Deeper troubleshooting and optimisation questions for HMGN2, answered from its protein features.

Which band should guide the blot?

Use 9.4 kDa, the observation attached to the authoritative A04839-2 WB record.

How should calculated mass be interpreted?

Treat the UniProt calculated mass as context; it does not replace the catalog-observed 9.4 kDa expectation.

Which positive control should I start with?

Start with Lung, the lead HPA protein-expression candidate.

Which negative control is defensible?

Use a target knockdown/knockout control when no HPA Not detected tissue is available.

Which gel should I use?

Use 15% consistently across the quick facts, protocol table, and poster.

What transfer method to use for HMGN2 Western blot?

Use the transfer method in the recommended protocol and verify transfer before blocking.

How should A04839-2 be started?

Start at the linked datasheet condition and run a three-point primary-antibody dilution test.

Which publication-derived protocols can I compare?

Compare only the supplied target-verified records: PMC13130554, PMC12611830, PMC12911437.

Boster reagents

HMGN2 Western Blot Reagents

Human-reactive HMGN2 Western blot reagents with authoritative product imagery.

Real WB data Western blot validation image for HMGN2 using A04839-2; observed band 9.4 kDa

Anti-HMGN2 Antibody Picoband®

Cat # A04839-2

Reactivity: Human

View product →

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.